Molecular Targets and Therapeutic Pathways in Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Drug Development".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 2
Special Issue Editors
Interests: mechanisms of viral oncogenesis; development of viral-based therapeutics for cancer; understanding the cancer virome and glioma immunology; identification of novel drug targets for brain tumors
Interests: abacavir; antiretroviral; drug repurposing; glioblastoma; lamivudine; reverse transcriptase inhibitors
Special Issue Information
Dear Colleagues,
Cancer remains one of the leading causes of mortality worldwide, making continued innovation in the development of therapeutic options a necessity. This Special Issue, “Molecular Targets and Therapeutic Pathways in Cancer”, aims to highlight recent advances in the identification of novel molecular targets and the elucidation of signaling pathways that drive the initiation, progression, and resistance of tumors. With the rapid expansion of genomics, proteomics, and high-throughput screening technologies, researchers are now better equipped to unravel the complex biology underlying cancer and translate these insights into more precise and effective therapies. We welcome original research articles, reviews, and perspectives that explore oncogenic signaling networks, targeted therapy development, resistance mechanisms, and emerging strategies such as synthetic lethality, immunomodulation, and drug repurposing. By showcasing cutting-edge work in this area, this Special Issue aims to foster collaboration and innovation at the interface of basic science and clinical translation.
Dr. Ashish H. Shah
Dr. Deepa Seetharam
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer therapeutics
- molecular targets
- signal transduction pathways
- targeted therapy
- drug resistance
- precision oncology
- tumor microenvironment
- immunotherapy
- kinase inhibitors
- translational cancer research
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
